12:00 AM
 | 
Apr 27, 2015
 |  BC Week In Review  |  Company News  |  Deals

Faulk Pharmaceuticals, Panther Biotechnology deal

Panther will acquire Faulk’s pharmaceutical assets, including TRF-DOX, for an undisclosed number of Panther shares. TRF-DOX is a...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >